Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Colostrum and whey could have a role in TB control
dairy cows
High sensitivity tests may be key to bTB eradication, researchers say.
Australian researchers highlight the importance of high sensitivity tests

Colostrum and colostral whey could have an important role to play in the control and eradication of bovine TB in the UK, according to researchers from the University of Adelaide in Australia.

Writing in the Veterinary Record letters, researchers from the university's School of Animals and Veterinary Sciences, said recent research has underlined the need for tests with high diagnostic sensitivity.

A new test for alpacas may even have applications for cattle, they said. The recently launched multiplex TB immunoassay shows superior sensitivity compared to the intradermal test for alpacas.

Recent research on Johne's disease in vaccinated sheep also found that using colostrum or colostral whey showed a significant increase in antibody ELISA sensitivity.

"We are not aware of any current research in the UK on bovine TB or Johne's disease using colostrum or colostral whey to parameterise antibody assays and wish to draw attention to the potential of these samples to increase diagnostic sensitivities," they wrote

"Colostrum is readily available on dairy farms and is easy to collect and store. Current bovine TB and Johne's disease research projects may be able to incorporate the collection of colostrum without major additional expense."

The full letter can be found in Vet Record Vol 175 No 23.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'